Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B

Human cytomegalovirus glycoprotein B (gB) represents a target for diagnosis and treatment in view of the role it plays in virus entry and spread. Nevertheless, to our knowledge, rare detection of a gB antigen has been reported in transplant patients and limited information is available about diagnos...

Full description

Bibliographic Details
Main Authors: Fan Jun, Li Minhuan, Ma Yadan, Huang Yaping, Liang Hanying, Hu Jianhua, Yao Hangping, Ma Weihang
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2012-07-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000700004&lng=en&tlng=en
id doaj-80d1e916ab2d4c17bb322f39701fc737
record_format Article
spelling doaj-80d1e916ab2d4c17bb322f39701fc7372020-11-24T23:43:19ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2012-07-01457583590S0100-879X2012000700004Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein BFan Jun0Li Minhuan1Ma Yadan2Huang Yaping3Liang Hanying4Hu Jianhua5Yao Hangping6Ma Weihang7Zhejiang UniversityZhejiang UniversityZhejiang UniversityZhejiang UniversityZhejiang UniversityZhejiang UniversityZhejiang UniversityZhejiang UniversityHuman cytomegalovirus glycoprotein B (gB) represents a target for diagnosis and treatment in view of the role it plays in virus entry and spread. Nevertheless, to our knowledge, rare detection of a gB antigen has been reported in transplant patients and limited information is available about diagnostic gB monoclonal antibodies (mAbs). Our aim was to develop gB mAbs with diagnostic potential. Hydrophilic gB peptides (ST: amino acids 27-40, SH: amino acids 81-94) of favorable immunogenicity were synthesized and used to immunize BALB/c mice. Two mAbs, named ZJU-FH6 and ZJU-FE6, were generated by the hybridoma technique and limited serial dilution and then characterized by indirect ELISA, Western blotting, immunoprecipitation, and immunohistochemical staining. The mAbs displayed high titers of specific binding affinities for the ST and SH synthetic peptides at an mAb dilution of 1:60,000 and 1:240,000, respectively. Western blotting and immunoprecipitation indicated that these mAbs recognized both denatured and native gB of the Towne and AD169 strains. The mAbs, when used as the primary antibody, showed positive staining in cells infected with both Towne and AD169 strains. The mAbs were then tested on patients submitted to allogeneic hematopoietic stem cell transplantation. The gB antigen positivity rates of the patients tested using ZJU-FH6 and ZJU-FE6 were 62.0 and 63.0%, respectively. The gB antigen showed a significant correlation with the level of pp65 antigen in peripheral blood leukocytes. In conclusion, two potential diagnostic gB mAbs were developed and were shown to be capable of recognizing gB in peripheral blood leukocytes in a reliable manner.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000700004&lng=en&tlng=enHuman cytomegalovirusGlycoprotein BMonoclonal antibodyAntigen detectionTransplantation
collection DOAJ
language English
format Article
sources DOAJ
author Fan Jun
Li Minhuan
Ma Yadan
Huang Yaping
Liang Hanying
Hu Jianhua
Yao Hangping
Ma Weihang
spellingShingle Fan Jun
Li Minhuan
Ma Yadan
Huang Yaping
Liang Hanying
Hu Jianhua
Yao Hangping
Ma Weihang
Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
Brazilian Journal of Medical and Biological Research
Human cytomegalovirus
Glycoprotein B
Monoclonal antibody
Antigen detection
Transplantation
author_facet Fan Jun
Li Minhuan
Ma Yadan
Huang Yaping
Liang Hanying
Hu Jianhua
Yao Hangping
Ma Weihang
author_sort Fan Jun
title Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
title_short Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
title_full Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
title_fullStr Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
title_full_unstemmed Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
title_sort development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein b
publisher Associação Brasileira de Divulgação Científica
series Brazilian Journal of Medical and Biological Research
issn 1414-431X
publishDate 2012-07-01
description Human cytomegalovirus glycoprotein B (gB) represents a target for diagnosis and treatment in view of the role it plays in virus entry and spread. Nevertheless, to our knowledge, rare detection of a gB antigen has been reported in transplant patients and limited information is available about diagnostic gB monoclonal antibodies (mAbs). Our aim was to develop gB mAbs with diagnostic potential. Hydrophilic gB peptides (ST: amino acids 27-40, SH: amino acids 81-94) of favorable immunogenicity were synthesized and used to immunize BALB/c mice. Two mAbs, named ZJU-FH6 and ZJU-FE6, were generated by the hybridoma technique and limited serial dilution and then characterized by indirect ELISA, Western blotting, immunoprecipitation, and immunohistochemical staining. The mAbs displayed high titers of specific binding affinities for the ST and SH synthetic peptides at an mAb dilution of 1:60,000 and 1:240,000, respectively. Western blotting and immunoprecipitation indicated that these mAbs recognized both denatured and native gB of the Towne and AD169 strains. The mAbs, when used as the primary antibody, showed positive staining in cells infected with both Towne and AD169 strains. The mAbs were then tested on patients submitted to allogeneic hematopoietic stem cell transplantation. The gB antigen positivity rates of the patients tested using ZJU-FH6 and ZJU-FE6 were 62.0 and 63.0%, respectively. The gB antigen showed a significant correlation with the level of pp65 antigen in peripheral blood leukocytes. In conclusion, two potential diagnostic gB mAbs were developed and were shown to be capable of recognizing gB in peripheral blood leukocytes in a reliable manner.
topic Human cytomegalovirus
Glycoprotein B
Monoclonal antibody
Antigen detection
Transplantation
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012000700004&lng=en&tlng=en
work_keys_str_mv AT fanjun developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT liminhuan developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT mayadan developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT huangyaping developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT lianghanying developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT hujianhua developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT yaohangping developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
AT maweihang developmentoftwopotentialdiagnosticmonoclonalantibodiesagainsthumancytomegalovirusglycoproteinb
_version_ 1725502022245941248